Hu and Chen [35] and Chen et al. [36] showed significantly lower levels of adropin in T2DM patients when compared to healthy subjects, additionally suggesting its possible participation in the pathogenesis and development of diabetic nephropathy. This evidence concerns the gene ENHO and diabetic kidney disease.